Bupleurum

Bupleurum falcatum L

Bibliografia

  • Abe H et al. (1986) J Ethnopharmacol; 18: 297
  • Abe H, Orita M, Konishi H, Arichi S, Odashima S (1985) “Effects of saikosaponin-d on enhanced CCl4-hepatotoxicity by phenobarbitone”. J Pharm Pharmacol.; 37(8): 555-9
  • Abe H, Orita M, Konishi H, Arichi S, Odashima S (1986) “Effects of saikosaponin-d on aminonucleoside nephrosis in rats” Eur J Pharmacol. 21; 120(2): 171-8
  • Abe H, Sakaguchi M, Arichi S(1982) “[Pharmacological studies on a prescription containing Bupleuri Radix (IV). Effects of saikosaponin on the anti-inflammatory action of glucocorticoid]” Nippon Yakurigaku Zasshi. ; 80(2): 155-61
  • Abe H, Sakaguchi M, Odashima S, Arichi S (1982) “Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat”. Naunyn Schmiedebergs Arch Pharmacol.; 320(3): 266-71
  • Abe H, Sakaguchi M, Yamada M, Arichi S, Odashima S (1980) “Pharmacological actions of saikosaponins isolated from Bupleurum falcatum. 1. Effects of saikosaponins on liver function”. Planta Med.; 40(4): 366-72
  • Bensky D, Gamble A, Kaptchuk T. (1993) Chinese Herbal Medicine Materia Medica, rev ed. Seattle: Eastland Press.
  • Blaschek W, Ebel S, Hackenthal E et al. (2002) HagerROM 2002: Hagers Handbuch der Drogen und Arzneistoffe. Heidelberg, Springer,
  • Bone K. (1996) “Bupleurum—a natural steroid effect, part 2.” MediHerb Professional Newsletter ;51:1–2.
  • Bone K. (2003) A Clinical Guide to Blending Liquid Herbs: Herbal Formulations for the Individual Patient, Churchill Livingstone,.
  • Buimovici-Klein E, Mohan V, Lange M, et al. (1990) “Inhibition of HIV replication in lymphocyte cultures of virus-positive subjects in the presence of sho-saiko-to, an oriental plant extract.” Antiviral Res;14:279–86.
  • Chang HM, But PP. (1987) Pharmacology and Applications of Chinese Materia Medica. Vol 2. World Scientific, Singapore.
  • Cheng, J.T.and Tsai,C.L. (1986) “Anti-inflammatory effect of saikogenin A” Biochem Pharmacol. 1; 35(15): 2483-7
  • Daibo A, Yoshida Y, Kitazawa S, Kosaka Y, Bando T, Sudo M (1992) “[A case of pneumonitis and hepatic injury caused by a herbal drug (sho-saiko-to)]” Nihon Kyobu Shikkan Gakkai Zasshi.; 30(8): 1583-8
  • Dong YY, Luo SQ (1989) “[Determination of saikosaponins in radix Bupleuri using HPLC]” Zhongguo Zhong Yao Za Zhi.; 14(11): 678-81, 703-4
  • Fujiwara K, Ogihara Y (1986) “Pharmacological effects of oral saikosaponin a may differ depending on conditions of the gastrointestinal tract”. Life Sci. 28; 39(4): 297-301
  • Fujiwara K, Ohta Y, Ogata I, et al. (1987) “Treatment trial of traditional Oriental medicine in chronic viral hepatitis”. In: Ohta Y (ed). New Trends in Peptic Ulcer and Chronic Hepatitis: Part II. Chronic Hepatitis. Tokyo: Excerpta Medica, 141–6.
  • Gibo Y, Nakamura Y, Takahashi N, et al. (1994) “Clinical study of sho-saiko-to therapy for Japanese patients with chronic hepatitis C (CH-C)”. Prog Med;14:217–9.
  • Hashimoto M, Inada K, Ohminami H, Kimura Y, Okuda H, Arichi S (1985) “Effects of Saikosaponins on liver tyrosine aminotransferase activity induced by cortisone in adrenalectomized rats”. Planta Med. ; 51(5): 401-3
  • Hattori T, Ito M, Suzuki Y (1991) “[Studies on antinephritic effects of plant components in rats (2): Effects of ginsenosides on original-type anti-GBM nephritis in rats and its mechanisms]” Nippon Yakurigaku Zasshi.; 97(2): 127-34
  • Hiai S, Yokoyama H (1986) “Chronic effect of saikosaponin on adrenal and thymus growth in normal and dexamethasone-treated rats hem” Pharm Bull (Tokyo).; 34(3):
  • Hiramatsu M, Edamatsu R, Kohno M, et al. The possible involvement of free radicals in seizure mechanism. Jpn J Psych 1986;40:349–52.
  • Hirayama C, Okumura M, Tanikawa K, et al. (1989) “ A multicenter randomized controlled clinical trial of sho-saiko-to in chronic active hepatitis”. Gastroent Jap;24:715–9.
  • Huang KC. (1993) The Pharmacology of Chinese Herbs. CRC Press, Boca Raton.
  • Hung CR, Wu TS, Chang TY (1993) “Comparison between the effects of crude saikosaponin and 16, 16-dimethyl prostaglandin E2 on tannic acid-induced gastric mucosal damage in rats”. Chin J Physiol.; 36(4): 211-7
  • Inoue T e Jackson EK (1999) “Strong antiproliferative effects in cultured rat hepatic stellate cells” Eur J Pharmacol 378:129-135
  • Ishizaki T, Sasaki F, Ameshima S, et al. (1996) “Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis”. Eur Respir J;9:2691–6.
  • Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M (1995) “Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang)”. Dig Dis Sci. ; 40(8): 1845-8
  • Kasahara Y, Hikino H, Tsurufuji S, Watanabe M, Ohuchi K (1985) “ Antiinflammatory actions of ephedrines in acute inflammations” Planta Med. ; 51(4): 325-31
  • Katou K, e Mori K (1999) “Autoimmune hepatitis with drug-induced pneumonia due to sho-saiko-to” Nihon Kokyuki Gakkai Zasshi; 37:641-646
  • Kumazawa Y, Kawakita T, Takimoto H, Nomoto K (1990) “Protective effect of saikosaponin A, saikosaponin D and saikogenin D against Pseudomonas aeruginosa infection in mice” Int J Immunopharmacol.; 12(5): 531-7
  • Leung CY, Liu L, Wong RN, Zeng YY, Li M, Zhou H (2005) “Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor”. Biochem Biophys Res Commun. 30; 338(4): 1920-7
  • Lin CC, Yen MH, Chiu HF, Chang CH (1990) “The pharmacological and pathological studies on Taiwan folk medicine (IV): The effects of echinops grijisii and e. Latifolius”. Am J Chin Med.; 18(3-4): 113-20
  • Matsumoto T, Sun XB, Hanawa T, Kodaira H, Ishii K, Yamada H (2002) “Effect of the antiulcer polysaccharide fraction from Bupleurum falcatum L. on the healing of gastric ulcer induced by acetic acid in rats” Phytother Res.; 16(1): 91-3
  • McGuffin M et al. (eds.) (1997) Botanical Safety Handbook CRC Press
  • Mills SY, Bone K (2005) The Essential Guide to Herbal Safety Churchill Livingstone
  • Miyazaki E, Ando M, Ih K, et al. (1998) “Pulmonary edema associated with the Chinese medicine shosaikoto”. Nihon Kokyuki Gakkai Zasshi;36:776–80
  • Mizushima Y, Oosaki R, Kobayashi M (1997) “Clinical features of pneumonitis induced by herbal drugs” Phytother Res 11(4):295-298
  • Motoo Y, Sawabu N.(1994) “Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines”. Cancer Lett;86:91–5.
  • Nagakubo S, Niwa S-I, Kumagai N, et al. (1993) “Effects of TJ-960 on Sternberg’s paradigm results in epileptic patients”. Jpn J Psych Neur;47:609–19.
  • Nakagawa A, Yamaguchi I, Takao T, Amano H. (1995) “Five cases of drug-induced pneumonitis due to sho-saiko-to or interferon alpha or both”. Nippon Kyobu Shikkan Gakkai Zasshi ;33:1361–6
  • Nakagawa Y, Hino J, Nakajima M, Tsukiyama K, Umeki S, Okimoto J, Yagi S, Soejima R (1989) “[Two cases of primary racemose hemangioma of the bronchial artery]” Nihon Kyobu Shikkan Gakkai Zasshi.; 27(12):
  • Nakatsuka M, Kumazawa Y, Matsuura M, Homma JY, Kiso M, Hasegawa A (1989) “Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives”. Int J Immunopharmacol.; 11(4): 349-58
  • Narita Y, Satowa H, Kokubu T, et al. (1982) “Treatment of epileptic patients with the Chinese herbal medicine ‘saiko-keishi-to’ (SK)”. IRCS Med Sci;10:88–9.
  • Nose M, Amagaya S, Ogihara Y (1989) “Effects of saikosaponin metabolites on the hemolysis of red blood cells and their adsorbability on the cell membrane” Chem Pharm Bull (Tokyo); 37(12):
  • Oka H, Yamamoto S, Kuroki T, et al. (1995) “Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-to (TJ-9)”. Cancer ;76:743–9.
  • Okita K, Li Q, Murakamio T, Takahashi M (1993) “Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells”. Eur J Cancer Prev. ; 2(2): 169-75
  • Packer M, Kligler B. (1984) “Bupleurum for the treatment of epilepsy”. Int J Chin Med 1984;1:55–8.
  • Pharmacopoeia Commission of the People’s Republic of China (1997) Pharmacopoeia of the People’s Republic of China, English Edn, Vol I. Chemical Industry Press, Beijing.
  • Piras G, Makino M, Baba M. (1997) “Sho-saiko-to, a traditional kampo medicine, enhances the anti-HIV-1 activity of lamivudine (3TC) in vitro”. Microbiol Immunol;41:435–9.
  • Sato A, Toyoshima M, Kondo A, et al. (1997) “Pneumonitis induced by the herbal medicine Sho-saiko-to in Japan”. Nippon Kyobu Shikkan Gakkai Zasshi;35:391–5
  • Shibata M (1970) “[Pharmacological studies on Bupleurum falcatum L. 3. Correlation between experimental pharmacological results and clinical applications of bupleurum]” Yakugaku Zasshi.; 90(3): 398-404
  • Shibata M, Yoshida R, Motoashi S, Fukushima M (1973) “[Pharmacological studies on Bupleurum falcatum L. IV. Some pharmacological effects of crude saikosides, saikogenin A and syrupy residue” Yakugaku Zasshi.; 93(12): 1660-7
  • Shimizu I (2000) “Sho-saiko-to: Japanese herbal medicine for protection against hepatic fibrosis and carcinoma”. J Gastroenter. Hepatol; 15(Suppl.):D84-D90
  • Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiha M, Horie T, Amagaya S e Kawada N (1999) “Herbal medicines for the liver: myths, proofs and treatments”. Gastroenterology; 117:
  • Shimizu K, Amagaya S, Ogihara Y (1985) “Structural transformation of saikosaponins by gastric juice and intestinal flora”. J Pharmacobiodyn.; 8(9): 718-25
  • Sugiyama H, Nagai M, Kotajima F, et al. (1995) “A case of interstitial pneumonia with chronic hepatitis C following interferon-alpha and sho-saiko-to therapy”. Arerugi;44:711–4
  • Sun XB, Matsumoto T, Yamada H (1991) “Effects of a polysaccharide fraction from the roots of Bupleurum falcatum L. on experimental gastric ulcer models in rats and mice”. J Pharm Pharmacol.; 43(10): 699-704
  • Tajiri H, Kozaiwa K, Osaki Y, et al. (1991) “The study of the effect of sho-saiko-to on HBeAg clearance in children with chronic HBV infection and with abnormal liver function tests”. Acta Paediatr Jpn; 94:1811–5.
  • Takada N, Arai S, Kusuhara N, Katagiri M, Yanase N, Abe T, Tomita T (1993) “[A case of sho-saiko-to-induced pneumonitis, diagnosed by lymphocyte stimulation test using bronchoalveolar lavage fluid]” Nihon Kyobu Shikkan Gakkai Zasshi.; 31(9): 1163-9
  • Takagi K, Shibata M (1969) “[Pharmacological studies on Bupleurum falcatum L. II. Antiinflammatory and other pharmacological actions of crude saikosides]” Yakugaku Zasshi.; 89(10):
  • Takeshita K, Saisho Y, Kitamura K, Kaburagi N, Funabiki T, Inamura T, Oyamada Y, Asano K, Yamaguchi K (2001) “Pneumonitis induced by ou-gon (scullcap)”. Intern Med. Aug ; 40(8): 764-8
  • Tanaka S, Takahashi A, Onoda K, Kawashima K, Nakaura S, Nagao S, Ohno Y, Kawanishi T, Nakaji Y, Kobayashi K (1986) “[Toxicological studies on biological effects of the herbal drug extracts in rats and mice. II. Moutan bark, Glycyrrhiza and Bupleurum root]” Yakugaku Zasshi.; 106(8): 671-86
  • Tang, W. and Eisenbrand, G. (1992) Chinese Drugs of Plant Origin, Springer-Verlag, Berlin
  • Ushio Y, Abe H (1992) “Inactivation of measles virus and herpes simplex virus by saikosaponin d”. Planta Med.; 58(2): 171-3
  • Ushio Y, Abe H. (1991) “The effects of saikosaponin-d on yeast phagocytosis and degradation in peritoneal macrophages: related increase in Fc receptor expression and altered cytoplasmic organization”. Jpn J Pharmacol.;56(2):167-75.
  • Ushio Y, Oda Y, Abe H (1991) “Effect of saikosaponin on the immune responses in mice”. Int J Immunopharmacol.; 13(5): 501-8
  • Utrilla MP, Zarzuelo A, Risco S, et al. (1991) “Isolation of a saikosaponin responsible for the antiinflammatory activity of Bupleurum gibralticum Lam root extract”. Phytother Res;5:43–5.
  • Wagner H, Hikino H, Farnsworth NR (eds). (1988) Economic and Medicinal Plant Research, Vol 2. Academic Press, London
  • Watanabe K, Fujino H, Morita T, et al. (1988) “Solubilization of saponins of Bupleuri radix with ginseng saponins: Cooperative effect of dammarene saponins”. Planta Med 1988;54:405–8.
  • World Health Organization (1989) Medicinal Plants in China. WHO Regional Office for the Western Pacific, Manilla.
  • World Health Organization (1998) Medicinal Plants in the Republic of Korea. WHO Regional Office for the Western Pacific, Manilla
  • Yamada H, Sun XB, Matsumoto T, Ra KS, Hirano M, Kiyohara H (1991) “Purification of anti-ulcer polysaccharides from the roots of Bupleurum falcatum”. Planta Med.; 57(6): 555-9
  • Yamamoto M, Kumagai A, Yamamura Y (1975) “Structure and action of saikosaponins isolated from Bupleurum falcatum L. II. Metabolic actions of saikosaponins, especially a plasma cholesterol-lowering action”. Arzneimittelforschung.; 25(8): 1240-3
  • Yamamoto S, Oka H, Kanno T, et al. (1989) “Controlled prospective trial to evaluate Shosaiko-to in preventing hepatocellular carcinoma in patients with cirrhosis of the liver”. Gan To Kagaku Ryoho (Jpn J Cancer Chemother);16:1519–24
  • Yamashiki M, Nishimura A, Nomoto M, et al. (1996) “Herbal medicine sho-saiko-to induces tumor necrosis factor-alpha and granulocyte colony-stimulating factor in vitro in peripheral blood mononuclear cells of patients with hepatocellular carcinoma”. J Gastro Hepatol;11:137–42.
  • Yokoyama H, Hiai S, Oura H (1981) “Chemical structures and corticosterone secretion-inducing activities of saikosaponins”. Chem Pharm Bull (Tokyo) ; 29(2): 500-4

Glossario